{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:20:02Z","timestamp":1778588402623,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG056407"],"award-info":[{"award-number":["R01 AG056407"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG066582"],"award-info":[{"award-number":["P30 AG066582"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG032947"],"award-info":[{"award-number":["U01AG032947"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jagp.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T16:10:27Z","timestamp":1630167027000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare"],"prefix":"10.1016","volume":"30","author":[{"given":"Lianlian","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie PW","family":"Bynum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donovan T.","family":"Maust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2021.08.010_bib0001","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amepre.2020.09.007","article-title":"Trends in co-prescribing of opioids and opioid potentiators among U.S. adults, 2007-2018","volume":"60","author":"Rhee","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jagp.2021.08.010_bib0002","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jagp.2021.08.010_bib0003","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2021.08.010_bib0004","unstructured":"U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Accessed February 11, 2021. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or"},{"key":"10.1016\/j.jagp.2021.08.010_bib0005","unstructured":"U.S. Food & Drug Administration. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). Accessed February 11, 2021.https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2021.08.010_bib0006","doi-asserted-by":"crossref","first-page":"w29","DOI":"10.1377\/hlthaff.28.1.w29","article-title":"Medicare Advantage Plans at a Crossroads\u2014Yet Again: the experience with private-plan contracting shows that assuring stable plan choices and extra benefits requires extra money","volume":"27","author":"Berenson","year":"2008","journal-title":"Health Aff"},{"key":"10.1016\/j.jagp.2021.08.010_bib0007","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1377\/hlthaff.2012.0773","article-title":"Medicare beneficiaries more likely to receive appropriate ambulatory services in HMOs than in traditional Medicare","volume":"32","author":"Ayanian","year":"2013","journal-title":"Health Aff"},{"key":"10.1016\/j.jagp.2021.08.010_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1377\/hlthaff.2016.1027","article-title":"Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in fee-for-service","volume":"36","author":"Huckfeldt","year":"2017","journal-title":"Health Aff"},{"key":"10.1016\/j.jagp.2021.08.010_bib0009","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7326\/M18-1795","article-title":"Hospital readmission rates in Medicare Advantage and traditional Medicare: a retrospective population-based analysis","volume":"171","author":"Panagiotou","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jagp.2021.08.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1762","article-title":"Trends in use of low-value care in traditional fee-for-service Medicare and Medicare Advantage","volume":"4","author":"Park","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jagp.2021.08.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2019.102278","article-title":"The effects of Medicare Advantage on opioid use","volume":"70","author":"Baker","year":"2020","journal-title":"J Health Econ"},{"key":"10.1016\/j.jagp.2021.08.010_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jgs.16825","article-title":"Benzodiazepine use among Medicare, commercially insured, and veteran older adults, 2013\u20132017","volume":"69","author":"Maust","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2021.08.010_bib0013","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jamda.2016.07.017","article-title":"Differences in nursing home quality between Medicare Advantage and traditional Medicare patients","volume":"17","author":"Chang","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2021.08.010_bib0014","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern Med"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474812100453X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474812100453X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:58:36Z","timestamp":1778587116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106474812100453X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S106474812100453X"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2021.08.010","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}